Human Fcγ-receptors selectively respond to C-reactive protein isoforms
The assay provides a novel, scalable approach to determine the molecular properties of CRP as a physiological ligand of FcγR-mediated bioactivities.
Authors
- Anna C. Henning
- Julia Thomé (ORCID: https://orcid.org/0000-0002-1962-9525)
- Hartmut Hengel (ORCID: https://orcid.org/0000-0002-3482-816X)
- Katja Hoffmann (ORCID: https://orcid.org/0000-0003-3749-9047)
- Karlheinz Peter (ORCID: https://orcid.org/0000-0002-8040-2258)
- Steffen U. Eisenhardt (ORCID: https://orcid.org/0000-0003-4471-3160)
- Philipp Kolb (ORCID: https://orcid.org/0000-0001-7935-217X)
- Haizhang Chen (ORCID: https://orcid.org/0000-0002-1993-7659)
- Johannes Zeller (ORCID: https://orcid.org/0000-0002-8122-9063)
- Johanna Seer
Institutions
- Baker Heart and Diabetes Institute (AU)
- University of Freiburg (DE)
- The University of Melbourne (AU)
- University Medical Center Freiburg (DE)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2025-05-19
- DOI
- https://doi.org/10.3389/fimmu.2025.1598605
- Citations
- 2
- Primary Topic
- Monoclonal and Polyclonal Antibodies Research
- Type
- article
- Field-Weighted Citation Impact
- 2.72